In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Currax Pharmaceuticals LLC

www.curraxpharma.com

Latest From Currax Pharmaceuticals LLC

Deal Watch: GSK Furthers Cancer Gene Therapy Plans Via Lyell Collaboration

GSK hopes the San Francisco biotech’s technology can help its cell therapy pipeline address solid tumors. Avacta partners with ADC on antibody-drug conjugates.

Deals Business Strategies

Finance Watch: Anchiano, TCR2, Hoth And Stealth Make Seven US Biopharma IPOs For 2019

Public Company Edition: Four more IPOs in the US bring the year's total to seven – all in February. Also, Agenus launched its digital security offering, MacroGenics leads recent follow-on offerings and four companies reveal new job cuts.

Financing Business Strategies

Finance Watch: In Obesity, Vivus Raises Cash For Deals, Orexigen Finds A Buyer

Public Company Edition: Strategies diverge in obesity as Vivus restructures debt and raises cash for a new deal and new focus, after Orexigen nears a sale of the company via bankruptcy court. Also, Clovis leads recent offerings, while layoffs are on the table at Catabasis.

Financing Business Strategies

Deal Watch: Gilead’s Immunology Collaboration With Verily Continues Pivot Away From Virology

Gilead’s tie-up with Google’s Verily will explore the immunological underpinnings of rheumatoid arthritis, lupus and GI disorders. Janssen acquires BeneVir and its oncolytic virus expertise, while United Therapeutics buys out SteadyMed.
Deals Commercial
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Generic Drugs
    • OTC, Consumer
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Dental & Oral Products
  • Gynecological, Urological
  • Neurology, Nervous System
  • Alias(es)
  • Pernix Therapeutics Holdings Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Currax Pharmaceuticals LLC
  • Senior Management
  • George Hampton, CEO
    Michelle Parsons, CFO
    Terry Evans, COO
    George P Jones, VP, Sales & Mktg.
  • Contact Info
  • Currax Pharmaceuticals LLC
    Phone: (800) 793-2145
    10 North Park Pl.
    Ste. 201
    Morristown, NJ 07960
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register